Home/Evommune/Gregory S. Moss, Esq.
GS

Gregory S. Moss, Esq.

Chief Business and Legal Officer

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2